Real-world safety of nivolumab in patients with non-small cell lung cancer (NSCLC) in Japan: Interim summary of post-marketing all-case surveillance

Real-world safety of nivolumab in patients with non-small cell lung cancer (NSCLC) in Japan: Interim summary of post-marketing all-case surveillance

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; pp. viii431 - viii432
Main Authors: Ohe, Y., Gemma, A., Nakagawa, K., Yamamoto, N., Saito, T., Akamatsu, A., Kuwano, K., Nakanishi, Y.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy288.088